Antibiotics List for Exam 1 CMOD Flashcards
(45 cards)
CIPROFLOXACIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Fluroquinolones
• MOA
o Bind and inhibit DNA gyrase (aka topoisomerase II) and topoisomerase IV.
o Inhibit DURING cutting step, preventing Reattachment
o DNA fragments accumulate leading to cell death
• Bacteria: E. COLI (resistance emerging), PSEUDOMONAS AERUGINOSA
• Bactericidal
Levofloxacin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Fluroquinolones
• MOA
o Bind and inhibit DNA gyrase (aka topoisomerase II) and topoisomerase IV.
o Inhibit DURING cutting step, preventing Reattachment
o DNA fragments accumulate leading to cell death
• Bacteria: E.coli?, Pseudomonas aeruginosa?
• Bactericidal
RIFAMPIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Rifamycin
• MOA
o Bind PROKARYOTIC specific RNA polymerase
o Prevents initiation of RNA synthesis but not elongation
• Easily crosses lipophilic surfaces important for treatment of:
o Mycobacteria (mycolic acid walls) – MYCOBACTERIUM TB
o Staphlococcus Epidermidis and Aureus (Biofilm)
o Bacterial Meningitis (BBB penetration)
o Enters phagocytic cells
• Bactericidal
*Prevents INITIATION of RNA synthesis
Rifaximin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Rifamycin
• MOA
o Bind PROKARYOTIC specific RNA polymerase
o Prevents initiation of RNA synthesis but not elongation
• Easily crosses lipophilic surfaces important for treatment of:
o Mycobacteria (mycolic acid walls)
o Staphlococcus Epidermidis and Aureus (Biofilm)
o Bacterial Meningitis (BBB penetration)
o Enters phagocytic cells
• Bactericidal
*Prevents INITIATION of RNA synthesis
METRONIDAZOLE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Nitroimidazole
• MOA
o Pro-drug – must first be reduced by ferredoxin (a nitroreductase) which turns the nitroimidazole in to a toxic radical the FRAGMENTS DNA.
o Ferredoxin only used in ANAEROBIC bacteria
• Bacteria: Only effective against anaerobes
• Bactericidal
COTRIMOXAZOLE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• DHFR Inhibitor/Sulfonamide combination drug of trimethroprim and sulfamethoxazole
• MOA
o Trimethroprim – inhibits PROKARYOTIC DHFR
o Sulfonamide - prevents step 1 of THF acid synthesis by preventing PABA and Pteridine reaction via Pteridine Synthetase
• Bacteria: E. COLI , Pneumocystis Jiroveci
• Bactericidal
Trimethoprim • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• DHFR inhibitor • MOA o Inhibition of PROKARYOTIC DHFR • Bacteria: ?? • Bactericidal
Sulfamethoxazole • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Sulfonamide • MOA o Inhibits step 1 of THF/DHF acid synthesis by preventing PABA and pteridine reaction via Pteridine Synthase inhibition • Bacteria: ?? • Bactericidal
DAPTOMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Lipopeptide Antibiotic
• Bind to bacterial membranes and cause rapid depolarization of membrane potential ultimately DNA, RNA, and protein synthesis failed leading to cell death
o NOT effective in lungs due to Surfactant
• Bacteria: Gram (+) bacteria
• Bactericidal
FIDAXOMICIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
C. Diff Drug
• MOA
o inhibits RNA synthesis by inhibiting sigma dependent transcription
• Bacteria: pseudomembranous colitis (C. Diff)
Nitroflurantoin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Broad-Spectrum • MOA o Get reduced by flavoproteins then alter ribosomes and other macromolecules • Bacteria: ?? • Bactericidal
***only reaches therapeutic concentrations IN URINE
GENTAMICIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
Amikacin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
Neomycin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
Streptomycin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
Tobramycin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Aminoglycoside
• MOA
o Initial action: Deterioration of outer membrane
o Low Conc.: bind to 30S and cause misreading
o High Conc.: trap ribosome at AUG and prevent any translation
• Bacteria: gram (-) aerobes, Pseudomonas
• Bactericidal
AZITHROMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Macrolides
• MOA
o Bind to 50S RSU (23S RNA part) and prevent AA transfer to new chain by blocking peptidyl Transferase
o Phagocytosed so may be carried by macrophages to infection site
• Bacteria: gram (-), gram (+)
• [low] = Bacteriostatic [high] = Bactericidal
CLARITHROMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Macrolides
• MOA
o Bind to 50S RSU (23S RNA part) and prevent AA transfer to new chain by blocking peptidyl Transferase
o Phagocytosed so may be carried by macrophages to infection site
• Bacteria: gram (-), gram (+)
• [low] = Bacteriostatic [high] = Bactericidal
ERYTHROMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Macrolides Least stable of macrolides, labile in stomach acid
• MOA
o Bind to 50S RSU (23S RNA part) and prevent AA transfer to new chain by blocking peptidyl Transferase
o Phagocytosed so may be carried by macrophages to infection site
• Bacteria: MYCOPLASMA PNEUMONIAE, gram (-), gram (+)
• [low] = Bacteriostatic [high] = Bactericidal
Quinpupristin/dalfopristin • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Streptogramins
• MOA:
o 50S binding of both (near where macrolides bind) close binding leads to SYNERGISTIC effect
• Bacteria: ??
• Bactericidal - if synergistic binding of both occurs
CLINDAMYCIN • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
Lincosamides
• MOA:
o 50S RSU binding at 23S RNA part (PEPTIDYL TRANSFERASE) and cause premature dissociation of peptidyl -tRNA
• Bacteria: MRSA – when used in conjunction with vacomycin, gram (+), anaerobes
• Bacteriostatic
Useful in Toxin Producing Infections because it prevents toxin production and slows bacterial growth
LINEZOLID • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• MOA
o bind 50S ribosome at UNIQUE SITE protein synthesis inhibitor
o NO CROSS RESISTANCE
• Bacteria: MRSA
DOXYCYCLINE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Tetracyclines
• MOA
o Bind 30S RSU (16S part) and inhibit protein synthesis by weaking ribosome-tRNA interaction
• Bacteria: gram (+), gram (-), some anaerobes
• Bacterstatic
*Mammals lack the ability to take it up so this helps with selectivity
TIGECYCLINE • Group (common root) • MOA (general and specific) • Bacteria Treated • Bacteriostatic or Bactericidal
• Tetracyclines
• MOA
o Bind 30S RSU (16S part) and inhibit protein synthesis by weaking ribosome-tRNA interaction
• Bacteria: gram (+), gram (-), some anaerobes
• Bacterstatic
*Mammals lack the ability to take it up so this helps with selectivity